SEC Info - Escalon Medical Corp. - ‘10-K’ for 6/30/22

SEC Info℠

Home

Help

Please Sign In

Escalon Medical Corp. – ‘10-K’ for 6/30/22 – ‘EX-101.CAL’

On: Wednesday, 9/28/22, at 4:12pm ET · For: 6/30/22 · Accession #: 862668-22-23 · File #: 0-20127

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/28/22  Escalon Medical Corp.             10-K        6/30/22   75:6.5M

Annual Report — Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.34M 
 2: EX-23.1     Consent of Expert or Counsel                        HTML     20K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
12: R1          Cover                                               HTML     51K 
13: R2          Document And Entity Information                     HTML     66K 
14: R3          Audit Information                                   HTML     25K 
15: R4          Consolidated Balance Sheets                         HTML    143K 
16: R5          Consolidated Balance Sheets (Parenthetical)         HTML     35K 
17: R6          Consolidated Statements Of Operations               HTML     95K 
18: R7          Consolidated Statements Of Shareholders' Equity     HTML     45K 
                and Comprehensive Loss                                           
19: R8          Consolidated Statements Of Cash Flows               HTML     89K 
20: R9          Consolidated Statements Of Cash Flows               HTML     41K 
                (Parenthetical)                                                  
21: R10         Organization and Description of Business            HTML     26K 
22: R11         Going concern (Notes)                               HTML     25K 
23: R12         Significant Accounting Policies                     HTML    115K 
24: R13         Intangible assets (Notes)                           HTML     42K 
25: R14         Accrued expense (Notes)                             HTML     43K 
26: R15         Line of credit (Notes)                              HTML     26K 
27: R16         Long-term Debt (Notes)                              HTML     29K 
28: R17         Capital Stock Transactions                          HTML     55K 
29: R18         Income Taxes                                        HTML     65K 
30: R19         Commitments and Contingencies                       HTML     23K 
31: R20         Retirement and post retirement plans (Notes)        HTML     29K 
32: R21         Related Party Transactions                          HTML     27K 
33: R22         Concentration of credit risk (Notes)                HTML     37K 
34: R23         Leases (Notes)                                      HTML     53K 
35: R24         Significant Accounting Policies (Policies)          HTML    153K 
36: R25         Significant Accounting Policies (Tables)            HTML     86K 
37: R26         Significant Accounting Policies Property Plant and  HTML     31K 
                Equipment (Tables)                                               
38: R27         Significant Accounting Policies Deferred revenue    HTML     29K 
                (Tables)                                                         
39: R28         Intangible assets (Tables)                          HTML     52K 
40: R29         Accrued expense (Tables)                            HTML     31K 
41: R30         Long-term Debt EIDL maturities (Tables)             HTML     27K 
42: R31         Income Taxes (Tables)                               HTML     61K 
43: R32         Retirement and post retirement plans (Tables)       HTML     29K 
44: R33         Concentration of credit risk (Tables)               HTML     34K 
45: R34         Leases (Tables)                                     HTML     44K 
46: R35         Organization and Description of Business (Details)  HTML     21K 
47: R36         Going concern (Details)                             HTML     23K 
48: R37         Significant Accounting Policies (Cash and Cash      HTML     24K 
                Equivalents) (Details)                                           
49: R38         Significant Accounting Policies (Inventory)         HTML     33K 
                (Details)                                                        
50: R39         Significant Accounting Policies (Accounts           HTML     27K 
                Receivable) (Details)                                            
51: R40         Significant Accounting Policies (Net Income (loss)  HTML     40K 
                Per Share) (Details)                                             
52: R41         Significant Accounting Policies Earning per share   HTML     71K 
                details (Details)                                                
53: R42         Significant Accounting Policies Property pant and   HTML     37K 
                equipment (Details)                                              
54: R43         Significant Accounting Policies advertising         HTML     21K 
                expense (Details)                                                
55: R44         Significant Accounting Policies deferred revenue    HTML     28K 
                (Details)                                                        
56: R45         Intangible assets (Details)                         HTML     43K 
57: R46         Accrued expense (Details)                           HTML     36K 
58: R47         Line of credit (Details)                            HTML     40K 
59: R48         Long-term Debt (Details)                            HTML     47K 
60: R49         Capital Stock Transactions (Stock Option Plans)     HTML     58K 
                (Narrative) (Details)                                            
61: R50         Capital Stock Transactions (Stock Option Activity)  HTML     61K 
                (Details)                                                        
62: R51         Income Taxes (Provision for Income Taxes)           HTML     27K 
                (Details)                                                        
63: R52         Income Taxes (Effective Income Tax Rate) (Details)  HTML     30K 
64: R53         Income Taxes (Components of Net Deferred Income     HTML     57K 
                Tax Assets and Liabilities) (Details)                            
65: R54         Income Taxes Operation loss carry forward           HTML     48K 
                (Details)                                                        
66: R55         Retirement and post retirement plans (Details)      HTML     27K 
67: R56         Retirement and post retirement plans - liability    HTML     27K 
                rollforward (Details)                                            
68: R57         Related Party Transactions (Details)                HTML     38K 
69: R58         Concentration of credit risk (Details)              HTML     79K 
70: R59         Leases (Details)                                    HTML     49K 
73: XML         IDEA XML File -- Filing Summary                      XML    133K 
71: XML         XBRL Instance -- esmc-20220630_htm                   XML   1.28M 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX    117K 
 8: EX-101.CAL  XBRL Calculations -- esmc-20220630_cal               XML    119K 
 9: EX-101.DEF  XBRL Definitions -- esmc-20220630_def                XML    596K 
10: EX-101.LAB  XBRL Labels -- esmc-20220630_lab                     XML   1.45M 
11: EX-101.PRE  XBRL Presentations -- esmc-20220630_pre              XML    930K 
 7: EX-101.SCH  XBRL Schema -- esmc-20220630                         XSD    130K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              371±   558K 
75: ZIP         XBRL Zipped Folder -- 0000862668-22-000023-xbrl      Zip    361K

‘EX-101.CAL’ — XBRL Calculations — esmc-20220630_cal

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="esmc-20220630.xsd#ConsolidatedBalanceSheets"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedBalanceSheets" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bb051eaa-dd4e-4c17-a4cd-5afd5a5bb998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:to="loc_us-gaap_AssetsCurrent_bb051eaa-dd4e-4c17-a4cd-5afd5a5bb998" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4d26b61a-3bc3-43e4-a902-97f962f5e116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4d26b61a-3bc3-43e4-a902-97f962f5e116" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1cb1480a-536e-412b-809d-4555fde096d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1cb1480a-536e-412b-809d-4555fde096d0" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fbffec84-2224-47a1-96e9-0d0ea7d6ac1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fbffec84-2224-47a1-96e9-0d0ea7d6ac1a" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_e38a2504-2141-4155-b508-916f9ad09a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1e22751-1654-4125-b5c0-bea65f4e9f49" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_e38a2504-2141-4155-b508-916f9ad09a58" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_379d4a0e-2794-499f-b576-8cae2e8027ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_179f4953-49b8-4101-a343-05de714b8d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_379d4a0e-2794-499f-b576-8cae2e8027ca" xlink:to="loc_us-gaap_Liabilities_179f4953-49b8-4101-a343-05de714b8d32" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_805a2af2-af0a-468f-a623-e81f131c674d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_379d4a0e-2794-499f-b576-8cae2e8027ca" xlink:to="loc_us-gaap_StockholdersEquity_805a2af2-af0a-468f-a623-e81f131c674d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c52d947d-6367-46f2-aa03-d094d61b5db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c52d947d-6367-46f2-aa03-d094d61b5db1" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4bc81b89-c076-4e3a-af7e-388f1c302410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:to="loc_us-gaap_RestrictedCashCurrent_4bc81b89-c076-4e3a-af7e-388f1c302410" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_70b6fa26-96de-4c40-8f3b-8c0107cd9b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_70b6fa26-96de-4c40-8f3b-8c0107cd9b18" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_993c0651-b8ee-4c07-9eef-b10d3e693509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:to="loc_us-gaap_InventoryNet_993c0651-b8ee-4c07-9eef-b10d3e693509" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6c06f629-4f6e-416c-bcef-fc4d45d0f32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_baf42432-9b01-494d-9412-1ab80785456c" xlink:to="loc_us-gaap_OtherAssetsCurrent_6c06f629-4f6e-416c-bcef-fc4d45d0f32a" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c4ac029a-8c9b-45ea-9ecd-6d4a7588d23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_aaefb256-3347-4d69-8700-b6e4f8a6cdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4ac029a-8c9b-45ea-9ecd-6d4a7588d23d" xlink:to="loc_us-gaap_PreferredStockValue_aaefb256-3347-4d69-8700-b6e4f8a6cdda" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a0e7da51-828a-4921-bf60-33efec4b5265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4ac029a-8c9b-45ea-9ecd-6d4a7588d23d" xlink:to="loc_us-gaap_CommonStockValue_a0e7da51-828a-4921-bf60-33efec4b5265" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a0790b69-c79d-4e63-86fe-3ab9a3c90d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4ac029a-8c9b-45ea-9ecd-6d4a7588d23d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a0790b69-c79d-4e63-86fe-3ab9a3c90d6e" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6085f6ba-7ac0-4f4f-9636-6a76837a4784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4ac029a-8c9b-45ea-9ecd-6d4a7588d23d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6085f6ba-7ac0-4f4f-9636-6a76837a4784" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3aca38b6-8b3d-436d-9163-7281455589a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_ShortTermBorrowings_3aca38b6-8b3d-436d-9163-7281455589a4" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBankCurrent_9e742dcb-0cf1-49b8-a05b-627601d4d774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableToBankCurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_NotesPayableToBankCurrent_9e742dcb-0cf1-49b8-a05b-627601d4d774" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNotesPayableCurrent_cd5e523a-60b8-4011-b8eb-3822f590343c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNotesPayableCurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_OtherNotesPayableCurrent_cd5e523a-60b8-4011-b8eb-3822f590343c" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_2fdaef90-b6b3-42f2-90b8-a312a4762a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_SecuredDebtCurrent_2fdaef90-b6b3-42f2-90b8-a312a4762a30" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f5011d54-337a-45ee-a048-6fb5f4794a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_AccountsPayableCurrent_f5011d54-337a-45ee-a048-6fb5f4794a70" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6dfe4656-2889-4b99-9235-b1dbaa9a1ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>

<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6dfe4656-2889-4b99-9235-b1dbaa9a1ce4" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_a25192a9-2cca-40c5-9bed-5cc5ed1fce9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>

<link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_a25192a9-2cca-40c5-9bed-5cc5ed1fce9b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4d85fbb2-9467-4717-b275-271327d853be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>

<link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4d85fbb2-9467-4717-b275-271327d853be" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_d37f6f89-c297-4e49-8071-1cff2a731e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>

<link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_DeferredRevenueCurrent_d37f6f89-c297-4e49-8071-1cff2a731e6d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d565d05c-6449-47a3-9980-fc07a267dc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>

<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7507bae-0cea-4d45-8fe3-ab92a94eaa58" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d565d05c-6449-47a3-9980-fc07a267dc72" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermNotesPayable_13a04e02-0f39-4774-a071-fc3c2f9a8d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermNotesPayable"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:to="loc_us-gaap_OtherLongTermNotesPayable_13a04e02-0f39-4774-a071-fc3c2f9a8d98" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_059e5ee5-0bf7-456d-a666-87adf6cef0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:to="loc_us-gaap_LongTermNotesPayable_059e5ee5-0bf7-456d-a666-87adf6cef0a8" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_999252b6-1c3b-43c2-abfd-ae40d2b60afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_999252b6-1c3b-43c2-abfd-ae40d2b60afe" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_479f01d5-cb91-458f-8812-9f2a84a281bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:to="loc_us-gaap_SecuredLongTermDebt_479f01d5-cb91-458f-8812-9f2a84a281bc" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6c16d20f-1f6e-409b-bf0a-0aeda2da1a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_75572844-4c85-43d0-8df7-e7d43fd1209c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6c16d20f-1f6e-409b-bf0a-0aeda2da1a63" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b979dee1-eb57-440b-bd11-68b0400bc2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_466be81a-d1e2-4a70-8a8b-d861800405a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b979dee1-eb57-440b-bd11-68b0400bc2e6" xlink:to="loc_us-gaap_LiabilitiesCurrent_466be81a-d1e2-4a70-8a8b-d861800405a6" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5a848249-f1c3-416f-954b-d42fdf88915f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b979dee1-eb57-440b-bd11-68b0400bc2e6" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_5a848249-f1c3-416f-954b-d42fdf88915f" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="esmc-20220630.xsd#ConsolidatedStatementsOfOperations"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_502ee2b6-2669-48dc-b82a-479dcdac58b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d1149540-bc44-4835-9b3d-3b0bc5b75570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_502ee2b6-2669-48dc-b82a-479dcdac58b6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d1149540-bc44-4835-9b3d-3b0bc5b75570" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a6782513-6302-4815-9ef7-2132a20110b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_502ee2b6-2669-48dc-b82a-479dcdac58b6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a6782513-6302-4815-9ef7-2132a20110b9" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1667f1bb-23e5-49e6-8cb4-1245c3b61aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>

<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_502ee2b6-2669-48dc-b82a-479dcdac58b6" xlink:to="loc_us-gaap_InterestExpense_1667f1bb-23e5-49e6-8cb4-1245c3b61aaf" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9252593e-509d-4496-86a7-c98f4c20852d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_12bf0de0-def0-474a-aed4-52c3b427234a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9252593e-509d-4496-86a7-c98f4c20852d" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_12bf0de0-def0-474a-aed4-52c3b427234a" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_00910cda-5626-4577-bb94-4cc34b9c2f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9252593e-509d-4496-86a7-c98f4c20852d" xlink:to="loc_us-gaap_NetIncomeLoss_00910cda-5626-4577-bb94-4cc34b9c2f0f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f69c8735-0804-432f-a4f4-32a79b1b8710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a4b3d09e-6af0-4825-8b94-d5b1ada5e76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f69c8735-0804-432f-a4f4-32a79b1b8710" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a4b3d09e-6af0-4825-8b94-d5b1ada5e76b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_863c0a0a-8187-4825-a09d-eea3cbfd2be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>

<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f69c8735-0804-432f-a4f4-32a79b1b8710" xlink:to="loc_us-gaap_CostsAndExpenses_863c0a0a-8187-4825-a09d-eea3cbfd2be3" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e0d600cf-6b1c-45c7-8558-223451cbdf98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_41496c14-3aba-4b9f-8599-30bc9e9bdf52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0d600cf-6b1c-45c7-8558-223451cbdf98" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_41496c14-3aba-4b9f-8599-30bc9e9bdf52" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_18f8b3db-dd99-43c5-87dc-9e6311766fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0d600cf-6b1c-45c7-8558-223451cbdf98" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_18f8b3db-dd99-43c5-87dc-9e6311766fec" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2da6d137-dc4c-4072-a321-abda3d7f32b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0d600cf-6b1c-45c7-8558-223451cbdf98" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2da6d137-dc4c-4072-a321-abda3d7f32b7" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="esmc-20220630.xsd#ConsolidatedStatementsOfCashFlows"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be075b7e-8f3e-4391-ae56-9ddf5802632e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_e2a53fc6-3317-437d-9408-1dfa48a9b94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_be075b7e-8f3e-4391-ae56-9ddf5802632e" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_e2a53fc6-3317-437d-9408-1dfa48a9b94f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_531e49d8-4253-4ea6-b6b1-482c1e82557b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e34f2df-10bb-47ea-92eb-8dc72050e56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_531e49d8-4253-4ea6-b6b1-482c1e82557b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e34f2df-10bb-47ea-92eb-8dc72050e56f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1240b10d-f9bf-485f-86d5-c0b9e6b67fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_531e49d8-4253-4ea6-b6b1-482c1e82557b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1240b10d-f9bf-485f-86d5-c0b9e6b67fc9" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b155d03a-f0f7-4f17-9df6-420ac3bb592b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_531e49d8-4253-4ea6-b6b1-482c1e82557b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b155d03a-f0f7-4f17-9df6-420ac3bb592b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_007017b3-c0b3-4e1d-ac77-9aec645c1f18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_007017b3-c0b3-4e1d-ac77-9aec645c1f18" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_c989bd2a-14b1-4181-88b9-96de82f0ecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_c989bd2a-14b1-4181-88b9-96de82f0ecb9" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c92ec18e-a1c8-4263-bfeb-3c86d28875b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c92ec18e-a1c8-4263-bfeb-3c86d28875b1" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e19414ec-bf71-47a0-9965-e6cc8c8d6b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>

<link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e19414ec-bf71-47a0-9965-e6cc8c8d6b48" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_59892eb4-4519-4994-8552-ed553c83d742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_59892eb4-4519-4994-8552-ed553c83d742" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4e49c1a9-11e3-4b0a-8ec7-0867b8cc7893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>

<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4e49c1a9-11e3-4b0a-8ec7-0867b8cc7893" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_8d63042f-d5c7-4045-b9e0-f2ad7d27ee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>

<link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_8d63042f-d5c7-4045-b9e0-f2ad7d27ee85" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_12d3df10-ae4b-4e0b-9262-07b73a20761a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>

<link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_12d3df10-ae4b-4e0b-9262-07b73a20761a" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_13297f95-4baa-464c-bdde-a7400e664a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>

<link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_NetIncomeLoss_13297f95-4baa-464c-bdde-a7400e664a69" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_721ccb39-bf12-4e44-b14f-ed6641b6706f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>

<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_721ccb39-bf12-4e44-b14f-ed6641b6706f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_508a30e0-7d3f-46c8-8ad5-a6a79763824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>

<link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_508a30e0-7d3f-46c8-8ad5-a6a79763824f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9d45d9d5-31ea-4ce2-bb7d-2cc55fc2c99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>

<link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9d45d9d5-31ea-4ce2-bb7d-2cc55fc2c99b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4b6b0f82-6fd6-45b2-9f38-8081f82dbfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>

<link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81da2384-b0d7-4660-b984-75d346e52b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4b6b0f82-6fd6-45b2-9f38-8081f82dbfb7" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_550644fb-60f8-45fa-9a94-aeca63e58488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_38f35327-bad7-4f58-8508-fba02ec19a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_550644fb-60f8-45fa-9a94-aeca63e58488" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_38f35327-bad7-4f58-8508-fba02ec19a9f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_aed893c0-f3de-47ba-b266-68ae4a4b5457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>

<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_550644fb-60f8-45fa-9a94-aeca63e58488" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_aed893c0-f3de-47ba-b266-68ae4a4b5457" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple" xlink:href="esmc-20220630.xsd#ConsolidatedStatementsOfCashFlowsParenthetical"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfed9fd6-2d2e-448d-929d-555f981c6435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08a96828-8f63-4d03-82c1-925fbc148d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfed9fd6-2d2e-448d-929d-555f981c6435" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08a96828-8f63-4d03-82c1-925fbc148d7f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_23b591cf-3510-441b-90b3-fc4aca1c4cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfed9fd6-2d2e-448d-929d-555f981c6435" xlink:to="loc_us-gaap_RestrictedCash_23b591cf-3510-441b-90b3-fc4aca1c4cda" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesEarningpersharedetailsDetails" xlink:type="simple" xlink:href="esmc-20220630.xsd#SignificantAccountingPoliciesEarningpersharedetailsDetails"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesEarningpersharedetailsDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ca17c8f-93fa-4bca-a2df-ccafd62cdd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6bbba2b9-81ed-461c-92b4-5a38dcde1c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ca17c8f-93fa-4bca-a2df-ccafd62cdd27" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6bbba2b9-81ed-461c-92b4-5a38dcde1c02" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_20e59e08-9df2-48f9-8c68-02b3440029fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ca17c8f-93fa-4bca-a2df-ccafd62cdd27" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_20e59e08-9df2-48f9-8c68-02b3440029fa" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.escalonmed.com/role/AccruedexpenseDetails" xlink:type="simple" xlink:href="esmc-20220630.xsd#AccruedexpenseDetails"/>

<link:calculationLink xlink:role="http://www.escalonmed.com/role/AccruedexpenseDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_c202247f-1f21-445a-9c39-56daa97a4849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_c202247f-1f21-445a-9c39-56daa97a4849" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_638da98a-d821-47e3-b49e-ef00d0a3ee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_638da98a-d821-47e3-b49e-ef00d0a3ee7b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_737d0db2-0cd5-4cca-9e33-28157e1de2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_737d0db2-0cd5-4cca-9e33-28157e1de2b0" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3189a5b5-8202-427c-90da-501eb165892b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3189a5b5-8202-427c-90da-501eb165892b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58fb7e93-1bcc-4236-a7b9-02ee4d8a80b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58fb7e93-1bcc-4236-a7b9-02ee4d8a80b7" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8ed80cc-59d6-480d-8403-1bfdab2723cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>

<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6208788-4ca0-4125-a58a-25e0fc21b284" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8ed80cc-59d6-480d-8403-1bfdab2723cd" xlink:type="arc"/>

</link:calculationLink>

</link:linkbase>

↑Top

Filing Submission 0000862668-22-000023 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Escalon Medical Corp. – ‘10-K’ for 6/30/22 – ‘EX-101.CAL’

On: Wednesday, 9/28/22, at 4:12pm ET · For: 6/30/22 · Accession #: 862668-22-23 · File #: 0-20127

Previous ‘10-K’: ‘10-K/A’ on 10/22/21 for 6/30/21 · Next & Latest: ‘10-K’ on 10/13/23 for 6/30/23

Annual Report — Form 10-KFiling Table of Contents

‘EX-101.CAL’ — XBRL Calculations — esmc-20220630_cal

This Exhibit is an XBRL XML File.

Annual Report — Form 10-K

Filing Table of Contents